Munteanu RA, Moldovan CS, Tigu AB, Drula R, Feder R, Magdo L, Jurj A, Raduly L, Budisan L, Pirlog R, Moldovan A, Zimta AA, Braicu C, Preda A, Munteanu V, Romitan M, Gulei D, Ciuleanu TE. 5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Med Pharm Rep [Internet]. 2024 Sep. 23 [cited 2025 Sep. 19];97(4):488-506. Available from: https://medpharmareports.com/index.php/mpr/article/view/2777